|
|
 |
|
Viewing report
|
|
|
|
Molecular Pathology in Drug Discovery and Development
John Wiley and Sons Ltd, Sep 2009, Pages: 373
Covers powerful new tools for drug development
Molecular pathology offers tools and techniques that can greatly enhance the drug discovery and development process, helping to make the promises of personalized medicine a reality. Molecular Pathology in Drug Discovery and Development provides an unmatched guide to this cutting-edge discipline and its applications to pharmaceutical science.
With contributions from leading lights in drug discovery, drug development, and molecular pathology balanced by a consistent editorial approach, this reference offers both an overview of molecular pathology and a close look at the methods as they are applied to the process of drug discovery and development. Presented as steps in the drug development process, the coverage includes the use of molecular pathology to:
- Identify and validate new drug candidates
- Enhance transcriptional profiling to better find and validate biomarkers
- Assess toxicology
- Employ toxicogenomics to identify genes relevant to the safety of compounds
- Identify correct doses for different drugs
- Identify patients for treatment
- Develop molecular therapies
- Further the new techniques of Immunohistochemistry and Immunofluorescence
With many tests and treatments already working today, drug research and development using molecular pathology has shown itself an extremely fruitful area. Molecular Pathology in Drug Discovery and Development gives practitioners an up-to-date resource on this highly active discipline and its role in furthering pharmaceutical research
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
Personalized Medicine - Scientific and Commercial Aspects
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
Biomarkers in Breast Cancer - 2011
Therapeutic Drug Monitoring - Technologies, Markets, and Companies
Biomarkers in Alzheimer's Disease - 2011
Biomarkers, Tests and Trends for Drug R&D
Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics
Companion Biomarkers in Drug Development
Lipid Nanocarriers in Cancer Diagnosis and Therapy
|
|
|
|
